Month: January 2026

GAITHERSBURG, Md., Jan. 07, 2026 (GLOBE NEWSWIRE) — Emergent BioSolutions Inc. (NYSE: EBS) announced today that Joe Papa, president and chief executive officer, will provide a company presentation during the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026 at 5:15 PM PST. The audio link for Emergent’s session may be accessed here and will be live for up to 30 days. The Company’s slides will be made available at the time of the presentation on the Investors section of the Emergent website. About Emergent BioSolutionsAt Emergent, our mission is to protect and save lives. For over 25 years, we’ve been at work preparing those entrusted with protecting public health. We deliver protective and life-saving solutions for health threats like smallpox, mpox, botulism, Ebola, anthrax and opioid overdose emergencies....

GREENWICH, Conn., Jan. 07, 2026 (GLOBE NEWSWIRE) — XPO (NYSE: XPO), a leading provider of freight transportation in North America, announced that it has renewed its long-standing commitment as the official transportation partner of the Susan G. Komen® 3-Day fundraising walks through March 2029.  “The 3-Day fundraising walks represent hope, strength and progress for those affected by breast cancer,” said Carolyn Roach, chief human resources officer of XPO. “Through our long-term partnership, we are proud to support Susan G. Komen’s mission while giving our employees meaningful ways to make an impact.”  XPO ensures that critical event materials safely reach every city on the 3-Day route by providing complimentary transportation, storage and logistical expertise. Employees also participate in the walks and fundraise in support of...

U.S.-based patients’ expectations for testing are changing, potentially at the expense of evidence-based medicine. Patients, feeling empowered by social media, want greater control over test ordering decisions, and some even dismiss doctors’ expertise, mirroring growing mistrust in authority.Infographic: Patient Expectations for Testing are EvolvingPatients have clear expectations for testing: 93% expect their doctor to order a lab test upon request, with nearly 1 in 5 patients having asked for a lab test based on information learned on social media. Meanwhile, 27% have pursued blood testing by a trusted lab provider out of curiosity, independent of a doctor’s recommendation.Tarrytown, New York, Jan. 07, 2026 (GLOBE NEWSWIRE) —93% of patients expect their doctor to order a test upon request 17% have requested a lab...

New energy platform initiative integrates battery storage, advanced energy management, and professional services to support electrification at scaleHypercorp Energy SolutionsHypercorp Energy Solutions expands Hypercharge into battery energy storage and intelligent energy management for commercial, fleet, and multi-family sites.VANCOUVER, British Columbia, Jan. 07, 2026 (GLOBE NEWSWIRE) — Hypercharge Networks Corp. (TSXV: HC; OTC: HCNWF; FSE: PB7) (the “Company” or “Hypercharge”), a leading, smart electric vehicle (EV) charging solutions provider and network operator, is pleased to announce the launch of Hypercorp Energy Solutions (“Hypercorp”), a new energy services initiative that operates alongside Hypercharge Networks and expands the Company’s focus beyond EV charging into the approximately $40 billion USD global battery...

CAMBRIDGE, Mass., Jan. 07, 2026 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today announced that the company will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, January 14, 2026 at 9:00 a.m. PT. A live webcast will be available on the Events and Presentations page in the Investors & Media section of Intellia’s website, www.intelliatx.com. A replay of the webcast will be available on Intellia’s website for approximately 30 days. About Intellia TherapeuticsIntellia Therapeutics, Inc. (NASDAQ:NTLA) is a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies. Since its inception, Intellia has focused on...

SEATTLE, Jan. 07, 2026 (GLOBE NEWSWIRE) — TappAlpha and Tuttle Capital Management, two innovators in ETF design, today jointly announced the launch of the T² Lift™ Series — a new line of ETFs seeking to offer light-leverage exposure to the daily income and growth strategies behind TSPY and TDAQ. The T² Lift™ Series aims to give investors 30% more exposure to the same daily growth and income strategies used in TSPY (S&P 500) and TDAQ (Nasdaq-100) — two of the fastest-growing ETFs in the market. These new funds use the same rules-based daily options approach, now with a light-leverage boost designed to increase both income potential and market participation. “Investors have been asking for a way to increase exposure to the TSPY and TDAQ strategy without reinventing the wheel,” said Si Katara, Founder and CEO at...

CLEVELAND, Jan. 07, 2026 (GLOBE NEWSWIRE) — Sotera Health Company (“Sotera Health” or the “Company”) (NASDAQ: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced that management will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026 at 1:30 p.m. Eastern Time / 10:30 a.m. Pacific Time. Company representatives will also participate in investor meetings during the conference. A live webcast of the presentation, along with accompanying materials, will be available on the Investor Relations section of the Company’s website at Presentation & Events | Sotera Health. A replay will be available within 48 hours following the presentation and will remain archived on the Company’s...